Liposomal encapsulated anthracyclines: new therapeutic horizons.
about
Liposomes as nanomedical devicesQuantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.Secretory phospholipase A₂ responsive liposomes.Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling.Emerging drugs for adult acute lymphoblastic leukaemia.NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelMechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo.Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis.Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma.Liposomal encapsulation diminishes daunorubicin-induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells.Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles.
P2860
Q28088315-7C52D527-7FA4-4A14-8F3E-28AD35A42D5DQ33958482-64820F62-CEA0-4019-BC32-C66C7BBCD78BQ34806920-1D1BE808-FF71-482F-A155-195B0B4E53F9Q35385515-2FC9167A-1A6B-49E5-A222-D5BE62CAAC71Q35641963-3F76A9A5-11CD-4D4C-B33F-F294A36CC8F4Q36219661-CC5AE8B4-3268-4FB4-9810-13658AD3C181Q36616645-750AD6AA-4594-445F-A9F2-BEDBFBEC1606Q36782265-CB5BA59E-3110-43C8-9A13-D98A6A3C3BB0Q36957793-78E6506E-C551-4035-AEBA-0B4361BFEC28Q37392719-24EF8FD0-C9F3-4799-BC64-DA44CDDC37A7Q39888100-176225CE-FC49-484A-B917-A8725A657B92Q43969507-FE7D97DD-E327-4E67-81DC-09C91A1BA89AQ49202265-76E24821-613C-4998-80FD-66D8A1E2B47D
P2860
Liposomal encapsulated anthracyclines: new therapeutic horizons.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Liposomal encapsulated anthracyclines: new therapeutic horizons.
@ast
Liposomal encapsulated anthracyclines: new therapeutic horizons.
@en
type
label
Liposomal encapsulated anthracyclines: new therapeutic horizons.
@ast
Liposomal encapsulated anthracyclines: new therapeutic horizons.
@en
prefLabel
Liposomal encapsulated anthracyclines: new therapeutic horizons.
@ast
Liposomal encapsulated anthracyclines: new therapeutic horizons.
@en
P1476
Liposomal encapsulated anthracyclines: new therapeutic horizons.
@en
P2860
P2888
P304
P356
10.1007/S11912-001-0016-5
P577
2001-03-01T00:00:00Z
P6179
1005497039